11C-choline PET/CT tumor recurrence detection and survival prediction in post-treatment patients with high-grade gliomas

18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT

(2013) Sellam Karunanithi et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Discriminating radiation necrosis from tumor progression in gliomas: a systematic review what is the best imaging modality?

(2013) Ashish H. Shah et al.   JOURNAL OF NEURO-ONCOLOGY

Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients

(2013) K. Herrmann et al.   NEURO-ONCOLOGY

Pseudoprogression in high-grade glioma

(2012) K. M. Knudsen-Baas et al.   ACTA NEUROLOGICA SCANDINAVICA

Imaging modalities in high-grade gliomas: Pseudoprogression, recurrence, or necrosis?

(2012) I. Caroline et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Pseudoprogression and Treatment Effect

(2012) Arman Jahangiri et al.   NEUROSURGERY CLINICS OF NORTH AMERICA

Comparison of MRI, F-18 FDG, and 11C-Choline PET/CT for Their Potentials in Differentiating Brain Tumor Recurrence From Brain Tumor Necrosis Following Radiotherapy

(2011) Haibo Tan et al.   CLINICAL NUCLEAR MEDICINE

F-18 FDG PET-CT for predicting survival in patients with recurrent glioma: a prospective study

(2011) Amburanjan Santra et al.   NEURORADIOLOGY

Recent Advances in Therapy for Glioblastoma

(2010) Jennifer Clarke et al.   ARCHIVES OF NEUROLOGY

Non-FDG PET in the practice of oncology

(2010) P Caroli et al.   INDIAN JOURNAL OF CANCER

Comparison of 18F-FDG and 11C-choline PET/CT for detecting recurrences in patients with nonsquamous cell head and neck malignancies

(2010) Kimiteru Ito et al.   NUCLEAR MEDICINE COMMUNICATIONS

New advances that enable identification of glioblastoma recurrence

(2009) Isaac Yang et al.   Nature Reviews Clinical Oncology

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas

(2008) Dieta Brandsma et al.   LANCET ONCOLOGY